ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
The male sling implantation for urinary incontinence after prostate surgery: a real-world multi-center study in China.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "The male sling implantation for urinary incontinence after prostate surgery: a real‑world multi‑center study in China".Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeUrinary incontinence after prostate treatment (IPT) is a distressing phenomenon. The aim of this real-world study was to evaluate the efficacy of the male sling in treating IPT in China.
methodsA total of 66 patients (83.8% with moderate and severe urinary incontinence) with IPT underwent male sling implantation in four medical centers. Incontinence was assessed using pad weight, pad usage per day (PPD), and the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Surgical efficacy, surgical modalities, BMI, and complications were evaluated.
resultsMedian follow-up was 23 months. Of 66 patients with transobturator (2-arm) and transobturator and anterior pubic (4-arm), 16 (24.2%) were cured, 40 (60.6%) improved, and 10 (15.1%) failed according to PPD. In terms of 24-h pad weights, 16 (24.2%) and 24 (36.3%) achieved continence (dry pad) or mild incontinence (< 100 mL/day); 22 (33.3%) and 4 (6%) were still with moderate (100-400 mL/day) or severe (> 400 mL/day) incontinence. Four (100.0%) patients preoperatively with mild incontinence were not cured, but all improved in terms of PPD. Of 39 patients preoperatively with moderate incontinence, 9 (23.1%) were cured, 24 (61.5%) improved, and 6 (35.8%) failed. Of 23 patients preoperatively with severe incontinence, 7 (30.4%) were cured, 12 (52.1%) improved, and 4 (17.4%) failed. The improvement rate for patients with three different levels of incontinence was 100%, 84.6%, and 82.6%, respectively. There was no significant correlation between the degree of recovery and BMI. Common postoperative complications include pain, incision infection, foreign body sensation, and urinary retention or dysuria.
conclusionThe majority of patients receiving male urethral sling implantation are moderate and severe patients. Real-world studies show that male urethral suspension is more often used to treat male urinary incontinence than AUS in China, and medical insurance policies and economic costs are important influencing factors. The utilization of this intervention has yielded a considerable rate of amelioration for IPT. It must also be admitted that comparative analysis indicates that male slings confer a superior overall prognostic improvement for patients presenting with mild urinary incontinence relative to those with moderate and severe manifestations of the condition, especially for severe urinary incontinence has improved, but a large proportion of patients still have symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.